GO:0090482 vitamin transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090482 (vitamin transmembrane transporter activity) is a molecular function that enables the transfer of a vitamin from one side of a membrane to the other.
• Vitamins are water-soluble or lipid-soluble micronutrients that often require dedicated membrane transporters because they cannot freely diffuse across lipid bilayers.
• The bile/arsenite/riboflavin transporter (BART) superfamily is a structurally defined group of vitamin transporters that includes riboflavin transporters.
• Cytochrome b561 family proteins mediate transmembrane electron transfer that is coupled to ascorbate (vitamin C) regeneration and recycling.
• Klotho proteins regulate vitamin D metabolism and ion transport, linking vitamin transporter activity to aging and mineral homeostasis.
• Dysregulated vitamin transport is implicated in hepatic cholestasis, metabolic disease, and disorders of vitamin homeostasis.
Description
GO:0090482, vitamin transmembrane transporter activity, is a molecular function term in the Gene Ontology that describes the transfer of a vitamin from one side of a membrane to the other. Vitamins are essential micronutrients that cannot be synthesized in sufficient quantities by humans and must be obtained from the diet or microbiota; their movement across cellular membranes is therefore a critical control point in metabolism. Because vitamins are often polar or charged, they require specialized transporter proteins rather than simple diffusion. The BART (bile/arsenite/riboflavin transporter) superfamily provides a structural and evolutionary framework for understanding how vitamin transporters recognize and translocate their substrates. Cytochrome b561 proteins, which are integral membrane electron carriers, are functionally coupled to ascorbate (vitamin C) handling and represent a distinct mechanistic class within vitamin-related transmembrane transport. Klotho is a pleiotropic protein that regulates vitamin D metabolism and ion transport, illustrating how vitamin transporter activity intersects with endocrine and aging biology. In hepatology, vitamin transport and cholestasis are linked through bile acid and vitamin absorption pathways, and progressive familial intrahepatic cholestasis exemplifies how transport defects cause disease. Autophagy regulation in hepatic metabolism further connects vitamin transport to cellular quality control and metabolic homeostasis. For researchers, GO:0090482 provides a precise annotation target for functional genomics, CRISPR screening, and structural biology of membrane proteins.
vitamin transmembrane transporter activity At A Glance
| GO ID | GO:0090482 |
|---|---|
| GO term | vitamin transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | vitamin or cofactor transporter activity; vitamin transporter activity |
| Major function | Transfer of a vitamin from one side of a membrane to the other |
| Substrate class | Vitamins (e.g., riboflavin, ascorbate, and related cofactors) |
| Representative family | BART (bile/arsenite/riboflavin transporter) superfamily |
| Related mechanism | Transmembrane electron transfer by cytochrome b561 proteins |
| Disease relevance | Cholestasis, metabolic disorders, and vitamin homeostasis defects |
What Is GO:0090482?
According to the Gene Ontology, GO:0090482 (vitamin transmembrane transporter activity) enables the transfer of a vitamin from one side of a membrane to the other. In practical terms, this means the gene product acts as a membrane-embedded protein that binds a vitamin substrate and facilitates its movement across a lipid bilayer, either down or against a concentration gradient depending on the coupling to energy sources. Synonyms include vitamin or cofactor transporter activity and vitamin transporter activity. This term is a molecular_function annotation and is distinct from broader transporter terms because it is restricted to vitamins as substrates.
Why Is vitamin transmembrane transporter activity Important in Cell Biology?
Vitamin transmembrane transporter activity is important because vitamins serve as enzyme cofactors and antioxidants, and their intracellular availability is dictated by transport proteins rather than passive diffusion. Defects in vitamin transporters can cause micronutrient deficiency even when dietary intake is adequate, and such defects are increasingly recognized in hepatic, metabolic, and neurological disease. The BART superfamily demonstrates that vitamin transport is an evolutionarily conserved function with structural determinants that can be targeted pharmacologically. Cytochrome b561 proteins show that ascorbate handling is mechanistically coupled to transmembrane electron transfer, linking vitamin transport to redox biology. Klotho connects vitamin D and mineral transport to aging and endocrine regulation. In liver disease, cholestasis alters bile flow and fat-soluble vitamin absorption, making transporter function clinically relevant. Autophagy and hepatic metabolism are also intertwined with vitamin availability and transport. Together, these findings make GO:0090482 a high-value annotation for functional studies and therapeutic hypothesis generation.
• Vitamins cannot generally cross membranes by simple diffusion, so dedicated transporters control their cellular uptake and distribution.
• The BART superfamily provides a structural template for riboflavin and related vitamin transport.
• Cytochrome b561 proteins couple ascorbate (vitamin C) regeneration to transmembrane electron transfer.
• Klotho regulates vitamin D metabolism and ion transport, linking vitamin transporter activity to aging.
• Progressive familial intrahepatic cholestasis illustrates how transport defects cause severe liver disease.
• Hepatic autophagy and metabolic regulation intersect with vitamin transport and storage.
• Vitamin transporter activity is a tractable target for CRISPR knockout and point-mutation studies.
• Membrane transporter proteins are attractive drug targets because their substrate pockets are structurally defined.
• Functional annotation of GO:0090482 supports genome-scale screening and bioinformatics analysis.
• Understanding vitamin transport helps explain inter-individual differences in vitamin status and disease risk.
Molecular Mechanism of vitamin transmembrane transporter activity
Substrate recognition and binding
In simple terms: The transporter must first grab the vitamin it is supposed to carry.
Vitamin transporters recognize their substrates through specific binding pockets formed by transmembrane helices. The BART superfamily, which includes riboflavin transporters, illustrates how a conserved fold can accommodate vitamin substrates and related compounds. Substrate recognition is the first committed step in transmembrane transport and determines specificity within the broader class of vitamin transporters.
Transmembrane translocation
In simple terms: Once bound, the vitamin is moved through the membrane.
After binding, the transporter undergoes conformational changes that move the vitamin from one side of the membrane to the other. This step defines the molecular function GO:0090482, which is the transfer of a vitamin across a membrane. The BART superfamily provides structural insight into how this translocation is achieved for riboflavin and related substrates.
Electron transfer and ascorbate coupling
In simple terms: Some vitamin-related transport processes are powered by electron movement.
Cytochrome b561 proteins are integral membrane proteins that mediate transmembrane electron transfer, a process functionally linked to ascorbate (vitamin C) recycling. Inhibition of electron acceptance from ascorbate by specific N-carbethoxylations of maize cytochrome b561 demonstrates a common mechanism for transmembrane electron transfer in this protein family. This couples vitamin C handling to redox chemistry across the membrane.
Regulation by Klotho and endocrine signals
In simple terms: Hormone-like proteins can tune how vitamins are handled.
Klotho is a pleiotropic protein that regulates vitamin D metabolism and ion transport, thereby influencing vitamin-related homeostasis. Klotho and aging studies show that this regulation has systemic consequences for mineral and vitamin balance. Thus, vitamin transmembrane transporter activity can be modulated by endocrine and aging-related pathways.
Integration with hepatic and metabolic pathways
In simple terms: The liver is a major hub for vitamin processing and transport.
Hepatic metabolism and autophagy influence vitamin availability and transport, and therapeutic regulation of autophagy in hepatic metabolism has been proposed as a strategy to modulate these pathways. Progressive familial intrahepatic cholestasis shows that transport defects in the liver cause disease, underscoring the clinical importance of vitamin and bile transport. These observations link GO:0090482 to liver physiology and metabolic disease.
Key Genes Involved in GO:0090482 vitamin transmembrane transporter activity
The following genes and protein families are representative of vitamin transmembrane transporter activity and related mechanisms, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BART superfamily members | Bile/arsenite/riboflavin transporter superfamily | Structural and evolutionary model for vitamin transport |
| Riboflavin transporters | Uptake of riboflavin (vitamin B2) | Prototype for BART-mediated vitamin transport |
| Cytochrome b561 | Transmembrane electron transfer coupled to ascorbate | Mechanistic link to vitamin C recycling |
| Klotho | Regulation of vitamin D metabolism and ion transport | Aging and endocrine biology |
| SLC13A1 | Na+-sulfate cotransporter | Related transport physiology and ion coupling |
| GPR155 | Cholesterol sensing and signal transduction | Membrane protein transport and sensing |
| Autophagy-related genes | Hepatic metabolic regulation | Vitamin and metabolite handling in liver |
| Cholestasis-related transporters | Bile and vitamin absorption | Disease modeling of transport defects |
| BART-like transporters | Vitamin or cofactor transport | Comparative genomics and functional annotation |
| Ascorbate recycling enzymes | Vitamin C regeneration | Redox biology and transporter coupling |
| Klotho-related ion channels | Mineral homeostasis | Vitamin D and ion transport integration |
| Hepatic metabolic regulators | Autophagy and metabolism | Therapeutic target discovery |
| Bile acid transporters | Enterohepatic circulation | Cholestasis and vitamin malabsorption |
| Membrane electron carriers | Transmembrane redox | Cytochrome b561 family studies |
| Vitamin D metabolic enzymes | Vitamin D activation/inactivation | Klotho-dependent regulation |
| Solute carrier family members | Ion and nutrient transport | Comparative transporter biology |
| Membrane receptors | Signal transduction | GPR155 as a model |
How Is vitamin transmembrane transporter activity Regulated?
Vitamin transmembrane transporter activity is regulated at multiple levels. Klotho modulates vitamin D metabolism and ion transport, providing endocrine control of vitamin handling. Hepatic autophagy and metabolic pathways influence vitamin availability and transport, and therapeutic regulation of autophagy has been proposed in hepatic metabolism. Cholestasis alters bile flow and fat-soluble vitamin absorption, indirectly regulating vitamin transport capacity. At the protein level, cytochrome b561 activity is sensitive to chemical modification, as shown by N-carbethoxylation effects on electron transfer from ascorbate. These layers of regulation allow cells to adjust vitamin transport to metabolic demand and stress.
vitamin transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Cholestasis-related transporters | Progressive familial intrahepatic cholestasis | Knockout hepatocyte models |
| Klotho | Aging and mineral homeostasis | Klotho knockout or overexpression models |
| BART superfamily members | Riboflavin transport deficiency | Point-mutation knock-in models |
| Cytochrome b561 | Ascorbate recycling defects | Tagged knock-in for electron transfer studies |
| Autophagy-related genes | Hepatic metabolic disease | CRISPR knockout in liver cell lines |
Progressive familial intrahepatic cholestasis and vitamin malabsorption
Progressive familial intrahepatic cholestasis is a severe liver disease in which bile flow is impaired, leading to cholestasis and malabsorption of fat-soluble vitamins. Transport defects in the liver directly affect vitamin absorption and distribution, making vitamin transmembrane transporter activity clinically relevant. Experimental models of cholestasis can be used to study how transporter dysfunction contributes to disease.
Aging and mineral homeostasis
Klotho is a key regulator of vitamin D metabolism and ion transport, and its decline is associated with aging-related phenotypes. Klotho and aging studies link vitamin transporter activity to systemic mineral homeostasis and longevity pathways. This makes Klotho an important gene for studying GO:0090482 in the context of aging.
Hepatic metabolism and autophagy
Therapeutic regulation of autophagy in hepatic metabolism is an emerging strategy that intersects with vitamin transport and storage. Autophagy influences the availability of vitamins and cofactors, and its dysregulation can contribute to metabolic disease. Studying vitamin transporters in hepatic models can clarify how autophagy and transport cooperate.
Riboflavin and BART-related disorders
The BART superfamily includes riboflavin transporters, and mutations in such transporters can impair riboflavin uptake. Riboflavin is an essential cofactor for many enzymes, so defective transport can have broad metabolic consequences. BART proteins therefore serve as a model for understanding vitamin transporter-related disease mechanisms.
From vitamin transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate vitamin transporter alter cellular vitamin uptake? | CRISPR knockout cell line |
| Does a specific point mutation in a transporter abolish substrate recognition? | Point-mutation knock-in |
| Can a tagged transporter be used to track localization? | Tagged knock-in |
| Does overexpression of a transporter increase vitamin flux? | Overexpression cell model |
| Does Klotho regulate vitamin D transport? | Klotho knockout or overexpression |
| Does autophagy modulation affect vitamin transport? | CRISPR knockout of autophagy genes |
How to Study the vitamin transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for vitamin transport | Discovery of new transporters |
| Structural biology | Protein fold and substrate binding | BART and cytochrome b561 studies |
| RNA-seq | Transporter gene expression | Metabolic and disease profiling |
| Proteomics | Protein abundance and modifications | Transporter regulation studies |
| Functional uptake assays | Vitamin transport rate | Validation of GO:0090482 annotations |
| Electron transfer assays | Transmembrane redox activity | Cytochrome b561 mechanism |
| Disease model phenotyping | Liver and metabolic phenotypes | Cholestasis and autophagy studies |
| Bioinformatics annotation | GO term enrichment and networks | Genome-scale analysis |
CRISPR knockout screening
Genome-scale CRISPR knockout screens can identify genes required for vitamin transport and cellular fitness under vitamin-limited conditions. Such screens are powerful for discovering new transporters and validating GO:0090482 annotations.
Structural biology and biochemistry
Structural studies of BART superfamily proteins and cytochrome b561 provide mechanistic insight into substrate recognition and transmembrane electron transfer. Biochemical assays can measure transport activity and electron transfer in reconstituted systems.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal how vitamin transporter expression changes in response to metabolic stress, autophagy modulation, or Klotho signaling. These methods help link transporter activity to disease pathways.
Disease modeling and functional assays
Cholestasis and hepatic metabolism models can be used to test how vitamin transport defects contribute to disease phenotypes. Functional assays of vitamin uptake and distribution provide direct evidence for transporter activity.
How CRISPR Can Be Used to Study GO:0090482 vitamin transmembrane transporter activity
Knockout
CRISPR knockout of candidate vitamin transporter genes can abolish transport activity and reveal cellular phenotypes under vitamin-limited conditions. Knockout models are essential for establishing causality between a gene and GO:0090482 activity.
Point Mutation
Point-mutation knock-in can be used to test specific residues predicted to be required for substrate binding or translocation in vitamin transporters. Such models help distinguish loss-of-function from structural perturbations.
Knock-in
Tagged knock-in of transporter genes enables localization and interaction studies, as demonstrated for cytochrome b561 family proteins. Knock-in of disease-associated variants can model transporter-related disorders.
Overexpression
Overexpression of vitamin transporters can increase cellular vitamin uptake and be used to study transport kinetics and downstream metabolic effects. Overexpression models complement knockout studies for bidirectional validation.
How EDITGENE Supports vitamin transmembrane transporter activity Research
Researchers studying vitamin transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in vitamin transport, how specific mutations affect transporter function, and whether overexpression or knockout alters cellular phenotypes. EDITGENE provides end-to-end CRISPR services to answer these questions with publication-ready models.
Contact EDITGENE today to design your custom CRISPR model for vitamin transmembrane transporter activity research.
Frequently Asked Questions About vitamin transmembrane transporter activity
What is GO:0090482?
GO:0090482 is the Gene Ontology molecular function term for vitamin transmembrane transporter activity, which enables the transfer of a vitamin from one side of a membrane to the other.
What genes are involved in vitamin transmembrane transporter activity?
Genes in the BART superfamily, riboflavin transporters, cytochrome b561, and Klotho are representative examples linked to vitamin transport and related mechanisms.
What is the BART superfamily?
The bile/arsenite/riboflavin transporter (BART) superfamily is a group of membrane transporters that includes riboflavin transporters and provides a structural framework for vitamin transport.
How is vitamin C related to transmembrane transport?
Cytochrome b561 proteins mediate transmembrane electron transfer that is functionally coupled to ascorbate (vitamin C) recycling.
Does Klotho regulate vitamin transport?
Klotho regulates vitamin D metabolism and ion transport, linking vitamin transporter activity to endocrine and aging biology.
What diseases are associated with vitamin transport defects?
Progressive familial intrahepatic cholestasis and related liver disorders are associated with transport defects that impair vitamin absorption.
How can I study vitamin transmembrane transporter activity in the lab?
CRISPR knockout, point-mutation knock-in, overexpression, structural biology, and functional uptake assays are common approaches.
What methods measure vitamin transport?
Functional uptake assays, electron transfer assays, RNA-seq, proteomics, and CRISPR screening can measure or infer vitamin transport activity.
Is autophagy related to vitamin transport?
Therapeutic regulation of autophagy in hepatic metabolism intersects with vitamin availability and transport pathways.
Why is GO:0090482 important for drug discovery?
Membrane transporters have defined substrate pockets and are attractive drug targets, making GO:0090482 relevant for therapeutic development.
Conclusion
GO:0090482 (vitamin transmembrane transporter activity) defines a critical molecular function that controls the movement of vitamins across cellular membranes. The BART superfamily and cytochrome b561 proteins provide mechanistic and structural insights, while Klotho links vitamin transport to aging and endocrine regulation. Disease connections include cholestasis and hepatic metabolic disorders, where transport defects impair vitamin absorption. CRISPR-based models and functional assays are essential for validating candidate transporters and advancing therapeutic hypotheses.
References
- 1. Byrnes K et al.. 2022. Therapeutic regulation of autophagy in hepatic metabolism.. Acta Pharm Sin B 12(1):33-49 PMID: 35127371
- 2. Srivastava A. 2014. Progressive familial intrahepatic cholestasis.. J Clin Exp Hepatol 4(1):25-36 PMID: 25755532
- 3. Kuro-o M. 2010. Klotho.. Pflugers Arch 459(2):333-43 PMID: 19730882
- 4. Markovich D. 2014. Na+-sulfate cotransporter SLC13A1.. Pflugers Arch 466(1):131-7 PMID: 24193406
- 5. Li D et al.. 2025. Structural insight into GPR155-mediated cholesterol sensing and signal transduction.. Sci Bull (Beijing) 70(21):3625-3637 PMID: 41058362
- 6. Kuro-o M. 2009. Klotho and aging.. Biochim Biophys Acta 1790(10):1049-58 PMID: 19230844
- 7. Nakanishi N et al.. 2009. Inhibition of electron acceptance from ascorbate by the specific N-carbethoxylations of maize cytochrome b561: a common mechanism for the transmembrane electron transfer in cytochrome b561 protein family.. J Biochem 146(6):857-66 PMID: 19762344
- 8. Mansour NM et al.. 2007. The bile/arsenite/riboflavin transporter (BART) superfamily.. FEBS J 274(3):612-29 PMID: 17288550
